Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus

NCT06691152 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: CD19 Universal CAR-T cells

Sponsor

The Children's Hospital of Zhejiang University School of Medicine